179 related articles for article (PubMed ID: 37531299)
1. Emerging drugs for dementia with Lewy Bodies: a review of Phase II & III trials.
Tolea MI; Ezzeddine R; Camacho S; Galvin JE
Expert Opin Emerg Drugs; 2023 Dec; 28(3):167-180. PubMed ID: 37531299
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
3. Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update.
MacDonald S; Shah AS; Tousi B
Drugs Aging; 2022 Jul; 39(7):505-522. PubMed ID: 35619045
[TBL] [Abstract][Full Text] [Related]
4. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
5. Clinical drug development for dementia with Lewy bodies: past and present.
Lee G; Cummings J; Decourt B; Leverenz JB; Sabbagh MN
Expert Opin Investig Drugs; 2019 Nov; 28(11):951-965. PubMed ID: 31614096
[No Abstract] [Full Text] [Related]
6. Advances in the pharmacotherapeutic management of dementia with Lewy bodies.
Palermo G; Ceravolo R; Bonuccelli U
Expert Opin Pharmacother; 2018 Oct; 19(15):1643-1653. PubMed ID: 30212224
[TBL] [Abstract][Full Text] [Related]
7. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
8. Dementia with Lewy bodies: emerging drug targets and therapeutics.
Pope ED; Cordes L; Shi J; Mari Z; Decourt B; Sabbagh MN
Expert Opin Investig Drugs; 2021 Jun; 30(6):603-609. PubMed ID: 33899637
[No Abstract] [Full Text] [Related]
9. Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022.
Abdelnour C; Gonzalez MC; Gibson LL; Poston KL; Ballard CG; Cummings JL; Aarsland D
Neurol Ther; 2023 Jun; 12(3):727-749. PubMed ID: 37017910
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism.
Panza F; Lozupone M; Watling M; Imbimbo BP
Expert Opin Pharmacother; 2021 Feb; 22(3):325-337. PubMed ID: 33021110
[TBL] [Abstract][Full Text] [Related]
11. Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies.
Broadstock M; Ballard C; Corbett A
Expert Opin Pharmacother; 2014 Sep; 15(13):1797-810. PubMed ID: 24992196
[TBL] [Abstract][Full Text] [Related]
12. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
[TBL] [Abstract][Full Text] [Related]
13. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis.
Donaghy PC; McKeith IG
Alzheimers Res Ther; 2014; 6(4):46. PubMed ID: 25484925
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
[TBL] [Abstract][Full Text] [Related]
15. Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?
Jellinger KA
Parkinsonism Relat Disord; 2022 Jul; 100():24-32. PubMed ID: 35691178
[TBL] [Abstract][Full Text] [Related]
16. No Significant Difference in Cognitive Decline and Mortality between Parkinson's Disease Dementia and Dementia with Lewy Bodies: Naturalistic Longitudinal Data from the Swedish Dementia Registry.
Fereshtehnejad SM; Lökk J; Wimo A; Eriksdotter M
J Parkinsons Dis; 2018; 8(4):553-561. PubMed ID: 30103351
[TBL] [Abstract][Full Text] [Related]
17. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Management of Dementia with Lewy Bodies.
Hershey LA; Coleman-Jackson R
Drugs Aging; 2019 Apr; 36(4):309-319. PubMed ID: 30680679
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic trials in dementia with Lewy bodies: a systematic review of the literature].
Sacrez M; Lamothe M; Rauch L; Botzung A; Blanc F
Geriatr Psychol Neuropsychiatr Vieil; 2021 Sep; 19(3):289-304. PubMed ID: 34609295
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibitors for dementia with Lewy bodies.
Wild R; Pettit T; Burns A
Cochrane Database Syst Rev; 2003; 2003(3):CD003672. PubMed ID: 12917981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
